MedPath

A comparison of intranasal Midazolam and intranasal Dexmedetomidine in paediatric burn wound dressings

Phase 4
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2024/01/061764
Lead Sponsor
ttar Pradesh University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)Patient of either sex belonging to ASA physical status I & II

2)Patients undergoing burn wound dressing.

3)Area of burn <30%

4)Ist and IInd degree burn

Exclusion Criteria

1)Patient refusal

2)Anticipated difficult airway

3)IIIrd degree burn

4)Patient having prior history of allergy with any of the drugs used in the study.

5)Patients with recent upper respiratory tract infection/ lower respiratory tract infection, nasal obstruction (mass), epistaxis, nasal congestion, sinusitis, congenital heart disease, mental retardation, or neurobehavioral problems.

•Patients with extensive burns involving the upper extremities, with no place for the attachment of blood pressure apparatus or pulse oximeter probes, were also excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Ramsay Sedation ScaleTimepoint: 5, 10, 15, 20, 25, and 30 min after drug administration
Secondary Outcome Measures
NameTimeMethod
hemodynamic parametersTimepoint: baseline,5, 10, 15, 30 min after drug administration.
© Copyright 2025. All Rights Reserved by MedPath